PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Helping good genes win in brain cancer cells

2013-12-20
(Press-News.org) Contact information: Rafael Roesler
rafael.roesler@pq.cnpq.br
55-513-359-7616
Write Science Right
Helping good genes win in brain cancer cells Porto Alegre, Brazil - Researchers at the Federal University of Rio Grande do Sul (UFRGS), the university hospital (Hospital de Clínicas de Porto Alegre, HCPA) and the Children's Cancer Institute (Instituto do Câncer Infantil do Rio Grande do Sul, ICI-RS) in Porto Alegre, Brazil, have shown that manipulating an epigenetic mechanism, which regulates gene expression, may promote cell death and favor maturation towards less malignant-prone phenotypes in pediatric brain cancer cell lines.

Cancer cells show alterations in gene expression related to modifications in the state of their chromatin, the "package" containing the genes in the cell nucleus. A group of enzymes called histone deacetylases (HDACs) helps to organize DNA within the cell nucleus by keeping chromatin in a more condensed state, thus inhibiting gene expression. The HDAC system is one component in the set of epigenetic mechanisms that regulate gene readout. There is growing interest in investigating compounds that inhibit HDACs, thereby allowing chromatin relaxation and increased gene expression, as candidate anticancer drugs.

Medulloblastoma is the most common type of childhood brain cancer. Although cure rates have improved, about 30% of patients with medulloblastoma tumors still have a low chance of being cured and survivors often experience long-term neurocognitive and neuroendocrine impairments.

In a study published in the December 2013 issue of the journal Molecular Neurobiology, Carolina Nör and colleagues – namely, study leader Rafael Roesler, ICI-RS researchers Caroline Brunetto de Farias, Ana Lucia Abujamra, and Algemir Lunardi Brunetto, and UFRGS and HCPA researchers Gilberto Schwartsmann, Felipe A. Sassi, and Guido Lenz - showed that sodium butyrate, a drug that acts on epigenetic regulation by inhibiting HDACs, reduces the survival of cultured medulloblastoma cells as well as formation of neurospheres in the cell cultures, which may indicate inhibition of cancer stem cell proliferation. In addition, cells treated with sodium butyrate showed enhanced mRNA expression of a marker of differentiation towards a mature neuronal phenotype. Finally, sodium butyrate enhanced the anticancer effect of the chemotherapeutic drug etoposide. These findings support and extend previous evidence indicating that HDAC inhibitors can reduce brain tumor growth by allowing genes involved in the promotion of cell death and maturation to be expressed.

"The use of HDAC inhibitors is currently the most important pharmacological approach to manipulate the epigenome. We are using cultured human brain tumor cell lines to identify novel effects of HDAC inhibitors. Although these findings need to be confirmed by in vivo experiments as well as by studies using cancer cells obtained directly from patients, our results support the view that these agents can allow the expression of genes related to cell death, or those involved in differentiation of tumor cells into mature brain cell types, hence having anticancer effects", says Roesler.

In addition to public research funding organizations, including the National Council for Scientific and Technological Development (CNPq) and the National Institute for Translational Medicine (INCT-TM), major support for the study was provided by the Rafael Koff Acordi Project, a research fund created by the Koff Acordi family in partnership with ICI-RS. "It is still uncommon to see basic cancer research being supported by private donations in Brazil, and we are working to promote this type of initiative", says Remi Acordi. "Our goal is to increasingly engage in basic research informed by clinical needs", says Algemir Brunetto, President of ICI-RS, a non-profit private organization focused on pediatric cancer treatment and research.

### Article: Carolina Nör, Felipe A. Sassi, Caroline B. de Farias, Gilberto Schwartsmann, Ana Lucia Abujamra, Guido Lenz, Algemir L. Brunetto, Rafael Roesler. The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells. Molecular Neurobiology 2013, 48: 533-543.

Financial support: The study was supported by the National Council for Scientific and Technological Development (CNPq); the Rafael Koff Acordi Research Fund, Children's Cancer Institute (ICI-RS); the National Institute for Translational Medicine (INCT-TM); and the South American Office for Anticancer Drug Development (SOAD).


ELSE PRESS RELEASES FROM THIS DATE:

Stanford and Google team up to simulate key drug receptor

2013-12-20
Stanford and Google team up to simulate key drug receptor Roughly 40 percent of all medications act on cells' G protein-coupled receptors (GPCRs). One of these receptors, beta 2 adrenergic receptor site (B2AR), naturally transforms between two base configurations; knowing ...

UT Southwestern neuroscience researchers identify gene involved in response to cocaine

2013-12-20
UT Southwestern neuroscience researchers identify gene involved in response to cocaine DALLAS – Dec. 19, 2013 – UT Southwestern neuroscience researchers have identified a gene that controls the response to cocaine by comparing closely related ...

ASU researchers develop new device to help image key proteins at room temperature

2013-12-20
ASU researchers develop new device to help image key proteins at room temperature TEMPE, Ariz. – A group of researchers from Arizona State University are part of a larger team reporting a major advance in the study of human proteins that could open up new avenues ...

91 new species described by California Academy Of Sciences in 2013

2013-12-20
91 new species described by California Academy Of Sciences in 2013 SAN FRANCISCO (December 20, 2013) — In 2013, researchers at the California Academy of Sciences discovered 91 new plant and animal species and two new genera, enriching our understanding ...

JCI early table of contents for Dec. 20, 2013

2013-12-20
JCI early table of contents for Dec. 20, 2013 Fungal surface protein promotes host cell Opportunistic infection of individuals on immunosuppressive therapy are a major problem for patient outcome, despite current prophylactic strategies. While the ability ...

Fungal surface protein promotes host cell

2013-12-20
Fungal surface protein promotes host cell Opportunistic infection of individuals on immunosuppressive therapy are a major problem for patient outcome, despite current prophylactic strategies. While the ability to prevent infection with well-characterized ...

Angiogenic factor secretion by melanocytes associated with pigmentation leve

2013-12-20
Angiogenic factor secretion by melanocytes associated with pigmentation leve The decreased vision loss that accompanies age-related macular degeneration (AMD) is associated with abnormal blood vessel growth in the eye. Frequencies of AMD development are ...

Nonsense suppression drug restores function in a mouse model of aniridia

2013-12-20
Nonsense suppression drug restores function in a mouse model of aniridia Congenital aniridia is a progressive disease that is associated with improper development of eye structures as well as abnormalities in the brain and pancreas. A variety of nonsense ...

Dysfunctional TGF-beta signaling contributes to Loeys-Dietz syndrome-associated aortic aneurysm

2013-12-20
Dysfunctional TGF-beta signaling contributes to Loeys-Dietz syndrome-associated aortic aneurysm Patients with the connective tissue disorder Loeys-Dietz syndrome (LDS) are at high risk for aortic aneurysm. LDS results in the presence of missense mutations ...

Evaluation of mangafodipir treatment for oxaliplatin-associated neuropathy

2013-12-20
Evaluation of mangafodipir treatment for oxaliplatin-associated neuropathy An unfortunate side effect of the platinum-chemotherapy drug oxaliplatin is the development of neurotoxicity, which can adversely affect a patient's quality of life; therefore, ...

LAST 30 PRESS RELEASES:

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

AI helps unravel a cause of Alzheimer's disease and identify a therapeutic candidate

Coalition of Autism Scientists critiques US Department of Health and Human Services Autism Research Initiative

Structure dictates effectiveness, safety in nanomedicine

[Press-News.org] Helping good genes win in brain cancer cells